FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24120811000001104: Palexia 20mg/ml oral solution (Grunenthal Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78960201000001115 Palexia 20mg/ml oral solution (Grunenthal Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78960301000001112 Palexia 20mg/ml oral solution (Grunenthal Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Is a Tapentadol 20mg/ml oral solution sugar free true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has active ingredient Tapentadol true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has specific active ingredient Tapentadol hydrochloride true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Is a Palexia true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) Has basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Palexia 20mg/ml oral solution (Grunenthal Ltd) 100 ml Has AMP True Palexia 20mg/ml oral solution (Grunenthal Ltd) Inferred relationship Existential restriction modifier
Palexia 20mg/ml oral solution (Grunenthal Ltd) 200 ml Has AMP True Palexia 20mg/ml oral solution (Grunenthal Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start